Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Income towards Parent Company (2022 - 2025)

Historic Income towards Parent Company for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$7.7 million.

  • CervoMed's Income towards Parent Company fell 6263.68% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.6 million, marking a year-over-year decrease of 11415.39%. This contributed to the annual value of -$16.3 million for FY2024, which is 11452.27% down from last year.
  • CervoMed's Income towards Parent Company amounted to -$7.7 million in Q3 2025, which was down 6263.68% from -$6.2 million recorded in Q2 2025.
  • CervoMed's Income towards Parent Company's 5-year high stood at -$1.2 million during Q2 2023, with a 5-year trough of -$7.7 million in Q3 2025.
  • In the last 4 years, CervoMed's Income towards Parent Company had a median value of -$2.8 million in 2022 and averaged -$3.8 million.
  • Per our database at Business Quant, CervoMed's Income towards Parent Company skyrocketed by 4205.55% in 2023 and then tumbled by 18404.8% in 2024.
  • Quarter analysis of 4 years shows CervoMed's Income towards Parent Company stood at -$4.1 million in 2022, then surged by 42.06% to -$2.4 million in 2023, then tumbled by 184.05% to -$6.7 million in 2024, then decreased by 15.16% to -$7.7 million in 2025.
  • Its Income towards Parent Company was -$7.7 million in Q3 2025, compared to -$6.2 million in Q2 2025 and -$4.9 million in Q1 2025.